Literature DB >> 7595358

Molecular relationships between 21 human rhinovirus serotypes.

C Horsnell1, R E Gama, P J Hughes, G Stanway.   

Abstract

We have analysed, by PCR using consensus primers followed by sequencing, 12 human rhinoviruses (HRVs) in a genomic region including that corresponding to the immunogenic site NIm-II. Together with published information, 21 sequences are available for comparison. In the region analysed, which encodes 112 amino acids, the majority (18) of the serotypes exhibited at least 70% amino acid identity to one another and some serotypes are very closely related. These include HRV-36, -58 and -89, known to exhibit antigenic cross reactivity, which were shown to differ at only three amino acid positions. Three serotypes, HRV-3, -14 and -72, share at least 84% identity with one another but are less than 66% identical to the majority group. Interestingly, membership of these two molecular clusters correlates with the groupings determined by sensitivity to antivirus drugs, suggesting that they reflect a fundamental division of HRVs. In contrast, there is no correlation with receptor grouping, since the majority group contains members belonging to both HRV receptor groups.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7595358     DOI: 10.1099/0022-1317-76-10-2549

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  19 in total

Review 1.  Methods for subtyping and molecular comparison of human viral genomes.

Authors:  M Arens
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

2.  Microarray-based detection and genotyping of viral pathogens.

Authors:  David Wang; Laurent Coscoy; Maxine Zylberberg; Pedro C Avila; Homer A Boushey; Don Ganem; Joseph L DeRisi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-12       Impact factor: 11.205

Review 3.  Clinical and molecular features of human rhinovirus C.

Authors:  Yury A Bochkov; James E Gern
Journal:  Microbes Infect       Date:  2012-01-12       Impact factor: 2.700

4.  Enzymatic characterization of refolded human rhinovirus type 14 2A protease expressed in Escherichia coli.

Authors:  Q M Wang; R B Johnson; G A Cox; E C Villarreal; L M Churgay; J E Hale
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

5.  Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor.

Authors:  S L Binford; F Maldonado; M A Brothers; P T Weady; L S Zalman; J W Meador; D A Matthews; A K Patick
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

6.  Evidence of recombination among enteroviruses.

Authors:  J Santti; T Hyypiä; L Kinnunen; M Salminen
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

7.  Amplicon sequencing and improved detection of human rhinovirus in respiratory samples.

Authors:  Christelle Deffernez; Werner Wunderli; Yves Thomas; Sabine Yerly; Luc Perrin; Laurent Kaiser
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

8.  Human rhinovirus species and season of infection determine illness severity.

Authors:  Wai-Ming Lee; Robert F Lemanske; Michael D Evans; Fue Vang; Tressa Pappas; Ronald Gangnon; Daniel J Jackson; James E Gern
Journal:  Am J Respir Crit Care Med       Date:  2012-08-23       Impact factor: 21.405

9.  Molecular diagnosis of human rhinovirus infections: comparison with virus isolation.

Authors:  T Hyypiä; T Puhakka; O Ruuskanen; M Mäkelä; A Arola; P Arstila
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

10.  VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds.

Authors:  Rebecca M Ledford; Nitesh R Patel; Tina M Demenczuk; Adiba Watanyar; Torsten Herbertz; Marc S Collett; Daniel C Pevear
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.